Information between 14th September 2025 - 24th September 2025
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Division Votes |
|---|
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 328 Noes - 160 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 303 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 314 Noes - 178 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 318 Noes - 170 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 304 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 332 Noes - 160 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 304 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 327 Noes - 164 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 172 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 158 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 326 Noes - 160 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 301 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 161 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 161 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 161 |
|
15 Sep 2025 - Employment Rights Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 301 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 329 Noes - 163 |
|
16 Sep 2025 - Sentencing Bill - View Vote Context Danny Beales voted Aye - in line with the party majority and in line with the House One of 278 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 340 Noes - 77 |
|
16 Sep 2025 - Sentencing Bill - View Vote Context Danny Beales voted No - in line with the party majority and in line with the House One of 277 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 78 Noes - 292 |
| Written Answers |
|---|
|
Prostate Cancer: Hormone Treatments
Asked by: Danny Beales (Labour - Uxbridge and South Ruislip) Friday 19th September 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2025 to Question 64681 on Prostate Cancer: Hormone Treatments, for what reason recurrent headroom in revenue budgets is considered a barrier to implementing the abiraterone acetate plus prednisone/prednisolone treatment. Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care) Reimbursement of abiraterone across all indications is managed at a national level by NHS England who must ensure the affordability of introducing any new routine commissioning policies, alongside maintaining existing services for patients and meeting their legal requirement to fund all National Institute for Health and Care Excellence (NICE) recommended medicines. Abiraterone has not been licensed for the treatment of high-risk, hormone sensitive, non-metastatic prostate cancer, and has not been assessed by NICE in this indication. NHS England therefore enabled a clinically-led review of the treatment in this indication determining it to be the highest priority for routine commissioning, and intends to commission the treatment for eligible patients as soon as recurrent funding is identified. |
| Parliamentary Debates |
|---|
|
Point of Order
5 speeches (603 words) Monday 15th September 2025 - Commons Chamber Mentions: 1: David Simmonds (Con - Ruislip, Northwood and Pinner) Member for Uxbridge and South Ruislip (Danny Beales) made reference to“the misquoting of things that - Link to Speech 2: Lindsay Hoyle (Spk - Chorley) Member for Uxbridge and South Ruislip (Danny Beales) of his intention to raise this matter? - Link to Speech |
| Select Committee Documents |
|---|
|
Wednesday 17th September 2025
Report - 3rd Report - Black Maternal Health Health and Social Care Committee Found: Current membership Layla Moran (Liberal Democrat; Oxford West and Abingdon) (Chair) Danny Beales (Labour |
| Calendar |
|---|
|
Tuesday 14th October 2025 1:15 p.m. Health and Social Care Committee - Private Meeting View calendar - Add to calendar |
| Select Committee Documents |
|---|
|
Wednesday 17th September 2025
Report - 3rd Report - Black Maternal Health Health and Social Care Committee |